VDAC1-based peptide as potential treatment for pathologies of the liver and pancreas

MLA

V. N. Nikolenko, et al. “VDAC1-Based Peptide as Potential Treatment for Pathologies of the Liver and Pancreas.” Медицинский Совет, no. 7, May 2022, pp. 92–97. EBSCOhost, https://doi.org/10.21518/2079-701X-2022-16-7-92-97.

APA

V. N. Nikolenko, N. A. Rizaeva, A. A. Bolotskaia, & K. V. Bulygin. (2022). VDAC1-based peptide as potential treatment for pathologies of the liver and pancreas. Медицинский Совет, 7, 92–97. https://doi.org/10.21518/2079-701X-2022-16-7-92-97

Chicago

V. N. Nikolenko, N. A. Rizaeva, A. A. Bolotskaia, and K. V. Bulygin. 2022. “VDAC1-Based Peptide as Potential Treatment for Pathologies of the Liver and Pancreas.” Медицинский Совет, no. 7 (May): 92–97. doi:10.21518/2079-701X-2022-16-7-92-97.